Consumption of meat, fish, dairy products, and eggs and risk of ischemic heart disease: A prospective study of 7198 incident cases among 409 885 participants in the Pan-European EPIC Cohort by Key, Timothy J. et al.
Circulation. 2019;139:2835–2845. DOI: 10.1161/CIRCULATIONAHA.118.038813 June 18/25, 2019 2835
Full author list is available on page 2843
Key Words: dairy products ◼ eggs  
◼ fish ◼ heart diseases ◼ meat
Sources of Funding, see page 2844
BACKGROUND: There is uncertainty about the relevance of animal foods 
to the pathogenesis of ischemic heart disease (IHD). We examined meat, 
fish, dairy products, and eggs and risk for IHD in the pan-European EPIC 
cohort (European Prospective Investigation Into Cancer and Nutrition).
METHODS: In this prospective study of 409 885 men and women in 9 
European countries, diet was assessed with validated questionnaires and 
calibrated with 24-hour recalls. Lipids and blood pressure were measured 
in a subsample. During a mean of 12.6 years of follow-up, 7198 
participants had a myocardial infarction or died of IHD. The relationships 
of animal foods with risk were examined with Cox regression with 
adjustment for other animal foods and relevant covariates.
RESULTS: The hazard ratio (HR) for IHD was 1.19 (95% CI, 1.06–1.33) 
for a 100-g/d increment in intake of red and processed meat, and this 
remained significant after exclusion of the first 4 years of follow-up (HR, 
1.25 [95% CI, 1.09–1.42]). Risk was inversely associated with intakes of 
yogurt (HR, 0.93 [95% CI, 0.89–0.98] per 100-g/d increment), cheese 
(HR, 0.92 [95% CI, 0.86–0.98] per 30-g/d increment), and eggs (HR, 
0.93 [95% CI, 0.88–0.99] per 20-g/d increment); the associations with 
yogurt and eggs were attenuated and nonsignificant after exclusion 
of the first 4 years of follow-up. Risk was not significantly associated 
with intakes of poultry, fish, or milk. In analyses modeling dietary 
substitutions, replacement of 100 kcal/d from red and processed meat 
with 100 kcal/d from fatty fish, yogurt, cheese, or eggs was associated 
with ≈20% lower risk of IHD. Consumption of red and processed meat 
was positively associated with serum non–high-density lipoprotein 
cholesterol concentration and systolic blood pressure, and consumption 
of cheese was inversely associated with serum non–high-density 
lipoprotein cholesterol.
CONCLUSIONS: Risk for IHD was positively associated with consumption 
of red and processed meat and inversely associated with consumption 
of yogurt, cheese, and eggs, although the associations with yogurt and 
eggs may be influenced by reverse causation bias. It is not clear whether 
the associations with red and processed meat and cheese reflect causality, 
but they were consistent with the associations of these foods with plasma 
non–high-density lipoprotein cholesterol and for red and processed meat 
with systolic blood pressure, which could mediate such effects.
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Ischemic heart disease (IHD) is the commonest dis-ease and cause of death in Europe.1 The risk of IHD is affected by diet, but there is uncertainty about the 
relevance of intake of animal foods such as red and 
processed meat, poultry, fish, dairy products, and eggs. 
Meat and dairy products are major dietary sources of 
saturated fatty acids; in the United Kingdom, for exam-
ple, meat and meat products contribute 24% of satu-
rated fat intake in adults, and milk and milk products 
contribute 22%.2 Controlled feeding trials have shown 
that high intakes of saturated fatty acids raise circulat-
ing low-density lipoprotein cholesterol, an established 
risk factor for IHD, suggesting that higher intakes of 
foods rich in saturated fatty acids may increase the risk 
of IHD.3,4 Meta-analyses of previous prospective studies 
of meat and the incidence of fatal IHD have suggested 
that intake of processed meat may be associated with 
higher risk, whereas intake of unprocessed red meat 
might not.5,6 For dairy products and eggs, systematic 
reviews of prospective studies have reported no con-
sistent evidence that higher intakes are associated 
with a higher risk of IHD.7,8 Consumption of fatty fish 
might reduce the risk of IHD because it is a rich source 
of long-chain n-3 fatty acids, and a meta-analysis has 
suggested an inverse association between overall fish 
consumption and mortality from IHD.9
Here, we report the relationships of these foods with 
the risk of IHD in EPIC (European Prospective Investi-
gation Into Cancer and Nutrition), a cohort of half a 
million men and women.10,11 To assess whether asso-
ciations might be the result of reverse causation, we 
examined the results after excluding the first 4 years 
of follow-up. To assess whether associations might be 
explained by known metabolic risk factors for IHD, we 
examined the cross-sectional associations of food in-
take with cholesterol fractions and blood pressure in a 
subsample of participants, interpreting the relationships 
of foods with risk with respect to their associations with 
non–high-density lipoprotein (HDL) cholesterol and sys-
tolic blood pressure.
METHODS
Because of the sensitive nature of the data collected for this 
study, requests to access the data set from qualified research-
ers trained in human subject confidentiality protocols may be 
sent to the International Agency for Research on Cancer at 
http://epic.iarc.fr/access/index.php.
Study Population
EPIC is a prospective study of ≈520 000 men and women 
recruited through 23 centers in 10 European countries, mostly 
between 1992 and 2000.10,11 Participants in EPIC completed 
dietary and lifestyle questionnaires, and the majority also 
provided blood samples and had their blood pressure mea-
sured. The baseline data were centralized at the World Health 
Organization’s International Agency for Research on Cancer in 
Lyon, France. All participants gave written informed consent, 
and the study protocol was approved by the ethics review 
boards of the International Agency for Research on Cancer 
and the institutions where participants were recruited.10
Dietary intake during the year before enrollment was mea-
sured by country-specific diet assessment methods, in most 
centers food frequency questionnaires; these were validated 
with a standardized, coordinated approach.10 Dietary intakes 
estimated with a standardized and computerized 24-hour 
recall method were also collected from an 8% random sam-
ple across all centers ≈1.4 years after recruitment. The sample 
was stratified by age and sex, with weighting according to 
predicted disease rates in these strata, and distributed equally 
by season and day of the week.12 Details of the categorization 
of foods are given in the online-only Data Supplement.
Assessments of the nondietary variables were based on 
responses in the baseline questionnaires and categorized into 
the following groups: smoking (never, former, current <10 or 
unknown number of cigarettes per day, current 10–19 ciga-
rettes per day, current ≥20 cigarettes per day, or unknown 
[2.4% of the cohort]); alcohol intake (not current drinker, sex-
specific fifths of current intake: cut points in men were 3.5, 
9.7, 18.8, and 36.2 g/d; cut points in women were 0.9, 2.8, 
6.9, and 13.9 g/d); physical activity (Cambridge physical activ-
ity index, based on occupational physical activity and cycling/
other physical exercise and categorized in approximate quar-
tiles called inactive, moderately inactive, moderately active, 
active, and unknown [2.2%])13; highest education level 
obtained (none or primary school only, secondary school, 
vocational qualification or university degree, unknown 
[4.3%]); employment status (currently employed or student, 
neither, unknown [11.4%]); and history of diabetes mellitus, 
hypertension, and hyperlipidemia (each self-reported: yes, no, 
unknown [4.2%, 5.5%, and 23.7%, respectively]). Body mass 
index (BMI; <22.5, 22.5–24.9, 25.0–27.4, 27.5–29.9, ≥30.0 
kg/m2, and unknown [0.9%]) was calculated from measured 
Clinical Perspective
What Is New?
• We followed up the health of 400 000 men and 
women in 9 European countries for 12 years to 
examine the relevance of intake of animal foods to 
the pathogenesis of ischemic heart disease.
• Higher consumption of red and processed meat 
was positively associated with the risk for ischemic 
heart disease.
• Consumption of the other animal foods examined 
was not positively associated with risk; intakes of 
fatty fish, yogurt, cheese, and eggs were modestly 
inversely associated with risk.
What Are the Clinical Implications?
• Higher intake of red and processed meat may 
increase the risk of ischemic heart disease.
• Substituting other foods for red and processed 
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height and weight (except for participants in Norway and 
some participants in France and the United Kingdom, for 
whom height and weight were self-reported). Baseline sys-
tolic and diastolic blood pressures were measured in millime-
ters of mercury by trained personnel (further details are given 
in the online-only Data Supplement).14
Lipids were measured in stored plasma samples as part 
of the EPIC-CVD (Cardiovascular Disease) case-cohort study, 
which is nested within EPIC.11 The subcohort was randomly 
selected from participants with a stored blood sample, with 
selection stratified by the 23 EPIC recruitment centers. Details 
of methods are given in the online-only Data Supplement.
Ascertainment and Verification of Cases 
of IHD
The outcome was IHD, defined as the composite of first non-
fatal myocardial infarction (MI; International Classification of 
Diseases, 10th Revision code I21) or death resulting from IHD 
(International Classification of Diseases, 10th Revision codes 
I20–I25). Incident nonfatal MIs were ascertained in each EPIC 
center with a combination of record linkage to morbidity or 
hospital registries and self-reports followed by confirmation 
with medical records.11 Information on vital status was col-
lected from mortality registries at the regional or national 
level in most centers except in Greece, where vital status was 
ascertained by active follow-up of study participants and next 
of kin. Centers in Denmark, Greece, Italy, Norway, and Spain 
validated all suspected cases of MI, whereas centers in France, 
the Netherlands, Sweden, and the United Kingdom validated 
a subset of the suspected cases to assess the accuracy of the 
overall ascertainment process. A range of methods was used 
to confirm the diagnosis of IHD and included retrieving and 
assessing medical records or hospital discharge notes, contact 
with medical professionals, retrieval and assessment of death 
certificates, or verbal autopsy with the next of kin. The last 
year of follow-up varied across centers between 2003 and 
2010 but was mainly 2008 or 2009.
Statistical Analysis
Of the 518 502 participants for whom data were available, 
those with no dietary data, no nondietary (lifestyle) data, and 
those in the top or bottom 1% of the ratio of energy intake 
to energy requirement were excluded (n=16 837), as were 
those who had a self-reported or unknown history of MI or 
stroke at baseline (n=11 308), 23 cases whose date of diag-
nosis was after the end of follow-up for each center, and 23 
participants with no follow-up data. These exclusions left a 
total of 490 311 participants, and further restricting the data 
set to EPIC centers with known values for all of the animal 
foods (which meant excluding Heidelberg, Potsdam, Naples, 
and Umeå) left a total of 409 885 participants, including 7198 
incident cases of nonfatal MI (n=5392) or fatal IHD (n=1806).
Follow-up was measured from recruitment until the date 
of first nonfatal MI or fatal IHD event or censoring at the date 
of death from other causes, nonfatal non-MI IHD, the date at 
which follow-up for IHD events was considered complete, or 
emigration or other loss to follow-up (1.3%). Relative risks as 
hazard ratios (HRs) and their 95% 95% CIs were estimated 
with Cox regression models. All analyses were stratified by 
sex and EPIC center and adjusted for exact age at recruit-
ment (continuous); smoking; self-reported history of diabetes 
mellitus, hypertension, and hyperlipidemia; physical activ-
ity; employment status; level of education; BMI (these last 8 
covariates were all categorical variables, with unknown cat-
egories added); current alcohol consumption (categorical); 
and intakes of energy, fruit and vegetables, dietary fiber from 
cereals, and percent energy from sugars (each continuous). In 
the main analyses of calibrated food intakes, the results for 
each animal source food were also adjusted simultaneously 
for the other animal source foods.
Participants were divided into fifths of self-reported intake 
for each animal food according to the recruitment question-
naire (for any foods with >20% zero values, the categories 
were approximate fifths), with the quintiles calculated for all 
included participants, and a trend test was performed by scor-
ing the categorical fifths of intake 1 to 5 and treating this 
as a continuous variable. To test for whether the data were 
compatible with a linear trend, we also fitted models with 
the fifths of intake treated as a categorical variable. There 
were no significant improvements in fit when we compared 
the categorical intake model with the continuous (trend test) 
intake model, suggesting that any associations between food 
intake and risk were approximately linear. Then, to improve 
the comparability of dietary data across participating centers 
and to correct for measurement error in relative risk estimates, 
the dietary data from the subset of participants with 24-hour 
recalls were used to provide statistically calibrated estimates 
of dietary intakes for all included participants. HRs were calcu-
lated for increments in observed and calibrated intake of each 
food. Observed food intakes were calibrated with a fixed-
effect linear model in which center- and sex-specific 24-hour 
recall data from an 8% random sample of the cohort were 
regressed on the observed intakes, generating a calibrated 
intake corresponding to each observed intake.12,15 The sizes 
of the increments were chosen to approximate the difference 
in mean 24-hour recall intake between participants in the 
lowest and highest fifths of observed intake and with refer-
ence to the increments used in previous publications such the 
World Health Organization’s review of the carcinogenicity of 
red and processed meat.16
Using the results from the mutually adjusted risks model, 
we estimated the effects of substituting 100 kcal/d of each 
other animal food for 100 kcal/d of red and processed meat 
from the ratios of the risk (as measured by the HR) for each 
food in turn and the risk for red and processed meat.17 For 
example, if P and R represent the HRs per 100 kcal/d yogurt 
and per 100 kcal/d red and processed meat in the mutually 
adjusted risks model, the effect of substituting 100 kcal/d 
yogurt for 100 kcal/d red and processed meat is estimated 
by the ratio P/R; the difference in covariance was used to esti-
mate the 95% CI.
To examine whether the overall results might be influ-
enced by reverse causality, we repeated the analyses after 
excluding the first 4 years of follow-up (ie, with follow-up 
for all participants beginning 4 years after the date of recruit-
ment). To examine whether associations between the animal 
foods and IHD risk were consistent across subgroups of other 
risk factors, we also conducted separate analyses for subsets 
of sex, smoking status (never, former, and current), prior dis-
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mellitus, hypertension, or hyperlipidemia), age at recruitment 
(<55, 55–64, ≥65 years), BMI (<25.0, 25.0–29.9, ≥30.0 kg/
m2), European region (Northern Europe: Denmark, Norway, 
and Sweden; Central Europe: France excepting Provence 
and Southwest France, the Netherlands, and the United 
Kingdom; Southern Europe: Greece, Italy, Spain, Provence, 
and Southwest France), and countries with partial (France, 
Netherlands, Sweden, and the United Kingdom) or complete 
(Denmark, Greece, Italy, Norway, and Spain) validation of 
cases. Tests for heterogeneity of trend between subgroups 
were obtained by comparing the risk coefficients for each 
subgroup using inverse variance weighting, testing for sta-
tistical significance with a χ2 test on k−1 df, where k is the 
number of subgroups.
To examine whether dietary risk factors might act through 
major established physiological IHD risk factors, we examined 
the associations of food intakes with non-HDL cholesterol and 
systolic blood pressure, calculating mean levels of these bio-
markers in each category of animal food intake (using linear 
regression to estimate least-squares means), with adjustment 
for age, sex, and EPIC center.
All analyses were performed with Stata version 15.1 (Stata 
Corp, College Station, TX), and a value of P<0.05 was consid-
ered statistically significant.
RESULTS
After a mean follow-up of 12.6 years, there were 7198 
incident cases of MI or death resulting from IHD. Ta-
ble 1 shows participant characteristics by sex for all co-
hort participants and for incident cases. On average, 
cases were 6 to 10 years older than average for the 
cohort, with higher mean BMI and lower mean alcohol 
intake. Cases were more likely to smoke; to be inactive, 
unemployed, and diabetic; and to have elevated blood 
pressure or proatherogenic lipids, lower mean observed 
intakes of fruit and vegetables; there were moderate 
differences in intakes of animal foods.
Table 2 shows the HRs and 95% CIs for IHD in each 
fifth of observed intake of animal foods, relative to the 
bottom fifth of intake, and P values for tests of trend 
based on the observed intakes. HRs in the top fifth of 
intake compared with the bottom fifth of intake were 
1.13 (95% CI, 1.02–1.26) for red and processed meat 
combined, 1.10 (95% CI, 0.99–1.21) for red meat, and 
1.10 (95% CI, 0.99–1.22) for processed meat. Intakes 
of poultry, white fish, fatty fish, milk, and eggs were 
not associated with IHD, whereas intakes of yogurt and 
cheese were inversely associated with risk, with HRs in 
the top fifths of 0.90 (95% CI, 0.84–0.97) and 0.88 
(95% CI, 0.80–0.96)
The Figure shows the associations of IHD risk with 
statistically calibrated increments in intake of 8 mutu-
ally exclusive animal foods (including red and processed 
meat combined but not red meat and processed meat 
separately), with mutual adjustment of risks for the ani-
mal foods (Table I in the online-only Data Supplement 
gives HRs for uncalibrated and calibrated increments 
without mutual adjustment). For red and processed 
meat combined, the HR was 1.19 (95% CI, 1.06–1.33) 
for a 100-g/d increment in calibrated intake. The HRs 
for calibrated intakes of yogurt (100 g/d), cheese (30 
g/d), and eggs (20 g/d) were 0.93 (95% CI, 0.89–0.98), 
0.92 (95% CI, 0.86–0.98), and 0.93 (95% CI, 0.88–
0.99), respectively.
In analyses excluding the first 4 years of follow-up, 
the association of risk with intake of red and processed 
meat was marginally stronger (HR per 100-g/d incre-
ment 1.25 [95% CI, 1.09–1.42]; P=0.001), whereas the 
associations with calibrated intakes of yogurt and eggs 
were attenuated, and neither these associations nor 
the association with cheese was statistically significant 
(Table 3).
Substitution Analyses
Table 4 shows the HRs for modeled substitution of 100 
kcal/d of calibrated intake of red and processed meat 
by 100 kcal/d of each of the other animal foods. Fatty 
fish, yogurt, cheese, and eggs were associated with sig-
nificantly lower risks for IHD than red and processed 
meat (15%–24% reductions in risk per 100 kcal sub-
stituted per day).
Subgroup Analyses
In analyses subdivided by history of diabetes mellitus, 
previous hypertension, or hyperlipidemia, there was 
no appreciable heterogeneity in the associations of 
animal foods with IHD risk except for white fish, but 
this was not significantly associated with risk in either 
subgroup (see Methods and Table II in the online-only 
Data Supplement). In analyses subdivided by smoking 
status, there was no appreciable heterogeneity in the 
associations of animal foods with IHD risk except for yo-
gurt, which was inversely associated with risk in current 
smokers but not in never smokers or former smokers 
(Table III in the online-only Data Supplement). In analy-
ses subdivided by age, there was no appreciable hetero-
geneity in the associations of animal foods with IHD risk 
except for red and processed meat, which was strongly 
positively associated with risk in participants recruited 
at <55 years of age but not in older people (Table IV 
in the online-only Data Supplement). In analyses sub-
divided by sex, there was no appreciable heterogeneity 
in the associations of animal foods with IHD risk except 
for eggs, which were inversely associated with risk in 
men but not in women (Table V in the online-only Data 
Supplement). There was no appreciable heterogeneity 
in the associations of animal foods with IHD risk subdi-
vided by BMI or by European region (Tables VI and VII in 
the online-only Data Supplement). There was evidence 
of heterogeneity by the extent of validation of cases 
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Table 1. Participant Characteristics at Recruitment in 409 885 Participants by Sex and Incident Case Status for First Nonfatal MI or 
Fatal IHD: EPIC Study
Characteristic
Men Women
All Men Male Cases All Women Female Cases
Participants, n 106 751 4608 303 134 2590
Age (SD), y 52.7 (10.3) 58.7 (8.3) 51.3 (9.8) 61.0 (8.5)
BMI (SD), kg/m2* 26.6 (3.7) 27.3 (3.8) 25.0 (4.4) 27.0 (4.7)
Alcohol in current drinkers (SD), g/d 22.4 (23.2) 20.6 (22.4) 9.2 (12.0) 7.9 (11.4)
Not current alcohol drinker, n (%) 5409 (5.1) 304 (6.6) 38 716 (12.8) 395 (15.3)
Smoking status and cigarettes/d, n (%)*
  Never smoker 32 986 (31.4) 926 (20.3) 168 240 (57.0) 1071 (41.7)
  Former smoker 38 347 (36.5) 1661 (36.5) 68 785 (23.3) 563 (21.9)
  Current smoker, <10 or number unknown 12 198 (11.6) 621 (13.6) 16 637 (5.6) 195 (7.6)
  Current smoker, 10–19 8216 (7.8) 513 (11.3) 23 900 (8.1) 436 (17.0)
  Current smoker, ≥20 13 281 (12.6) 835 (18.3) 17 522 (5.9) 306 (11.9)
Highest level of education completed, n (%)*
  None or primary 37 929 (36.8) 2129 (47.9) 85 431 (29.5) 1242 (51.8)
  Secondary 13 854 (13.4) 444 (10.0) 75 699 (26.2) 225 (9.4)
  Vocational or university 51 281 (49.8) 1868 (42.1) 128 157 (44.3) 930 (38.8)
Cambridge physical activity index, n (%)*
  Inactive 20 078 (19.4) 1188 (26.4) 65 052 (21.9) 866 (34.1)
  Moderately inactive 31 545 (30.4) 1365 (30.4) 103 286 (34.8) 855 (33.6)
  Moderately active 25 068 (24.2) 958 (21.3) 83 872 (28.2) 458 (18.0)
  Active 27 034 (26.1) 985 (21.9) 44 910 (15.1) 362 (14.2)
Employed or student, n (%)*
  Yes 68 176 (75.0) 2338 (58.2) 176 825 (64.9) 886 (37.1)
  No 22 727 (25.0) 1677 (41.8) 95 471 (35.1) 1503 (62.9)
History of diabetes mellitus, n (%)*
  No 100 468 (96.7) 4095 (93.0) 282 565 (97.8) 2233 (91.6)
  Yes 3379 (3.3) 308 (7.0) 6220 (2.2) 205 (8.4)
Previous hypertension, n (%)*
  No 83 183 (82.5) 3160 (73.0) 23 8272 (83.2) 1591 (64.4)
  Yes 17 697 (17.5) 1171 (27.0) 48 209 (16.8) 879 (35.6)
Prior hyperlipidemia, n (%)*
  No 67 978 (81.3) 2082 (73.7) 200 039 (87.2) 1230 (78.6)
  Yes 15 586 (18.7) 742 (26.3) 29 309 (12.8) 335 (21.4)
Region, n (%)†
  Northern Europe 34 924 (32.7) 2510 (54.5) 80 922 (26.7) 1253 (48.4)
  Central Europe 32 300 (30.3) 1059 (23.0) 135 150 (44.6) 936 (36.1)
  Southern Europe 39 527 (37.0) 1039 (22.5) 87 062 (28.7) 401 (15.5)
Energy intake (SD), kcal/d 2460 (650) 2436 (636) 1949 (536) 1878 (505)
Percent energy from sugars (SD) 17.3 (6.0) 17.7 (6.1) 19.4 (5.8) 20.5 (6.0)
Cereal fiber (SD), g/d 10.3 (5.7) 10.4 (6.0) 7.8 (4.4) 7.9 (4.6)
Fruit and vegetables (SD), g/d 455 (292) 387 (255) 484 (267) 423 (243)
Foods, median (lower and upper quartiles), g/d
  Red and processed meat 92 (54, 132) 101 (66, 142) 61 (35, 91) 66 (42, 95)
  Red meat 58 (30, 87) 60 (33, 89) 34 (16, 59) 40 (21, 62)
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red and processed meat and for milk (Table VIII in the 
online-only Data Supplement); for red and processed 
meat, there was a large and highly significant associa-
tion with risk in the countries with complete case veri-
fication but not in the other countries. For milk, there 
was a small positive association with risk in the coun-
tries with complete verification but not in the other 
countries.
Associations of Foods With Plasma Lipids 
and Blood Pressure
In a comparison of the participants in the highest fifth 
of intake of red and processed meat with those in the 
lowest fifth of such intake, non-HDL cholesterol was 
higher by 0.19 mmol/L (4.3%), and systolic blood pres-
sure was higher by 3.3 mm Hg (2.5%). For processed 
meat, the difference in systolic blood pressure between 
these groups of participants was 3.7 mm Hg (2.8%). 
Comparing participants in the highest fifth of intake 
of cheese with those in the lowest fifth of such intake 
showed that non-HDL cholesterol was lower by 0.10 
mmol/L, whereas the intake of cheese was unrelated 
to systolic blood pressure (see Tables IX and X in the 
online-only Data Supplement).
DISCUSSION
In this large European cohort, we observed a positive 
association between red and processed meat intake 
and risk of IHD, with a 19% (95% CI, 6–33) higher 
risk per 100-g/d increment in calibrated intake. Red 
and processed meat showed separate (albeit border-
line significant) associations with risk, which were 
each of similar magnitude. The association of risk with 
red and processed meat was observed after exclusion 
of the first 4 years of follow-up and in participants 
without diabetes mellitus, elevated blood pressure, or 
Mutually-adjusted hazard ratios (95% CI) for first non-fatal MI or fatal IHD





cases HR (95% CI) HR & 95% CI P for trend
Red and processed meat         100 7198 1.19 (1.06-1.33)    0.003
Poultry meat                    20 7198 0.99 (0.94-1.04)    0.68 
White fish                      15 7198 1.01 (0.97-1.04)    0.72 
Fatty fish                      15 7198 0.96 (0.92-1.01)    0.091
Milk                           200 7198 1.02 (0.99-1.06)    0.18 
Yogurt                         100 7198 0.93 (0.89-0.98)    0.007
Cheese                          30 7198 0.92 (0.86-0.98)    0.010
Eggs                            20 7198 0.93 (0.88-0.99)    0.023
0.8 1.0 1.2 1.5
Figure. Mutually adjusted hazard ratios (HRs; 95% CIs) for first nonfatal myocardial infarction or fatal ischemic heart disease per increment in statis-
tically calibrated intake of animal foods. 
HRs are adjusted for age (continuous), smoking status and number of cigarettes per day, history of diabetes mellitus, previous hypertension, prior hyperlipidemia, 
Cambridge physical activity index, employment status, level of education completed, body mass (all categorical, with unknown categories added), current alcohol 
consumption (nondrinkers and sex-specific fifths of intake among drinkers), and calibrated intakes of energy, fruit, and vegetables combined, sugars (as percent 
energy), fiber from cereals, and each other food (each continuous), and stratified in the analysis by sex and EPIC (European Prospective Investigation Into Cancer 
and Nutrition) center. HR indicates hazard ratio; IHD, ischemic heart disease; and MI, myocardial infarction.
  Poultry meat 16 (8, 33) 16 (6, 31) 14 (5, 23) 13 (4, 24)
  White fish 12 (3, 23) 14 (2, 25) 11 (2, 23) 10 (1, 20)
  Fatty fish 8 (2, 16) 8 (1, 17) 8 (2, 16) 7 (1, 16)
  Milk 171 (38, 321) 216 (55, 432) 148 (19, 294) 218 (70, 387)
  Yogurt 13 (0, 55) 8 (0, 61) 36 (3, 97) 27 (2, 94)
  Cheese 29 (15, 55) 25 (13, 51) 30 (16, 55) 23 (12, 42)
  Eggs 16 (7, 27) 17 (8, 29) 15 (7, 24) 14 (7, 23)
BMI indicates body mass index; EPIC, European Prospective Investigation Into Cancer and Nutrition; IHD, ischemic heart disease; and MI, myocardial 
infarction. 
*Value or category unknown for some participants.
†Northern Europe: Denmark, Norway, and Sweden (Malmö); Central Europe: France excepting Provence and Southwestern France, the Netherlands, 
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proatherogenic lipids. These additional results there-
fore reduce the likelihood of reverse causation or re-
sidual confounding. In comparison, a previous meta-
analysis of meat intake and risk of IHD reported that 
unprocessed red meat consumption was not associ-
ated with risk of IHD, whereas processed meat was, 
with a 42% higher risk per 50-g/d increment in in-
take.5 However, that previous review included only 
769 events from 4 studies for unprocessed red meat, 
including 1 case-control study; for processed meat, it 
included 21 308 events from 5 studies, but most cas-
es derived from 1 study for which the end point was 
total cardiovascular mortality rather than incident MI 
and fatal IHD. A subsequent meta-analysis also con-
cluded that processed meat but not unprocessed red 
meat was associated with IHD mortality, on the basis 
of up to 1370 deaths resulting from IHD.6 Hence, fur-
ther work is needed to understand potential reasons 
Table 2. HRs* (95% CIs) for First Nonfatal MI or Fatal IHD in 409 885 Participants by Overall Fifths of Observed (Self-Reported) Intake of Selected 
Animal Foods, Relative to the Bottom Fifth of Intake: EPIC Study
Food Cases, n
Fifth of Intake†
P for Trend‡2 3 4 5
Red and processed meat 7198 1.03 (0.93–1.13) 1.05 (0.95–1.15) 1.06 (0.96–1.17) 1.13 (1.02–1.26) 0.014
  Red meat 7198 0.98 (0.89–1.08) 1.05 (0.96–1.15) 1.06 (0.97–1.17) 1.10 (0.99–1.21) 0.016
  Processed meat 7198 0.98 (0.89–1.09) 1.03 (0.93–1.14) 1.07 (0.97–1.18) 1.10 (0.99–1.22) 0.007
Poultry meat 7198 1.00 (0.92–1.09) 0.99 (0.92–1.08) 1.00 (0.92–1.09) 1.01 (0.94–1.10) 0.77
White fish 7198 0.98 (0.90–1.07) 1.00 (0.92–1.08) 0.96 (0.89–1.04) 1.02 (0.94–1.11) 0.93
Fatty fish 7198 0.96 (0.88–1.03) 0.94 (0.88–1.02) 0.95 (0.88–1.03) 0.92 (0.86–0.99) 0.054
Milk 7198 0.91 (0.83–1.00) 0.97 (0.89–1.06) 0.97 (0.89–1.06) 0.97 (0.88–1.06) 0.66
Yogurt 7198 1.05 (0.97–1.14) 0.99 (0.92–1.07) 0.94 (0.87–1.02) 0.90 (0.84–0.97) 0.0004
Cheese 7198 0.95 (0.88–1.01) 0.90 (0.83–0.97) 0.91 (0.84–0.98) 0.88 (0.80–0.96) 0.003
Eggs 7198 0.96 (0.89–1.04) 0.97 (0.90–1.05) 1.02 (0.94–1.09) 0.93 (0.86–1.01) 0.37
EPIC indicates European Prospective Investigation Into Cancer and Nutrition; HR, hazard ratio; IHD, ischemic heart disease; and MI, myocardial infarction. 
*HRs are adjusted for age (continuous), smoking status and number of cigarettes per day, history of diabetes mellitus, previous hypertension, prior hyperlipidemia, 
Cambridge physical activity index, employment status, level of education completed, body mass index (all categorical, with unknown categories added), current 
alcohol consumption (nondrinkers and sex-specific fifths of intake among drinkers), and observed intakes of energy, fruit and vegetables combined, sugars (as 
percent energy), and fiber from cereals (each continuous), and stratified by sex and EPIC center.
†The median observed intakes (g/d) within each fifth of intake were as follows: red and processed meat: 12, 45, 67, 93, and 138; red meat: 3, 22, 39, 60, and 
94; processed meat: 1, 11, 22, 35, and 61; poultry meat: 0, 7, 15, 22, and 46; white fish: 0, 4, 11, 20, and 44; fatty fish: 0, 3, 8, 14, and 29; milk: 0, 49, 150, 288, 
and 470; yogurt: 0, 7, 27, 71, and 150; cheese: 5, 18, 30, 50, and 86; and eggs: 4, 9, 15, 22, and 40. For any foods with >20% zero values, the categories were 
approximate fifths. The mean 24-hour recall intakes (g/d) within each fifth of intake were as follows: red and processed meat: 37, 61, 75, 93, and 126; red meat: 24, 
33, 44, 54, and 69; processed meat: 10, 25, 34, 43, and 60; poultry meat: 11, 13, 17, 22, and 27; white fish: 11, 7, 13, 17, and 31; fatty fish: 8, 10, 12, 14, and 21; 
milk: 33, 79, 176, 240, and 384; yogurt: 15, 14, 34, 67, and 122; cheese: 15, 25, 33, 40, and 54; and eggs: 8, 12, 14, 18, and 26.
‡Tests of trend were performed scoring the fifths of intake 1 through 5.
Table 3. Mutually adjusted HRs* (95% CIs) for First Nonfatal MI or Fatal IHD in 406 908 Participants per Increment 
in Calibrated Intake of Selected Animal Foods After Exclusion of the First 4 Years of Follow-Up: EPIC Study
Food Increment, g/d Cases, n
HR (95% CI), Mutually 
Adjusted P for Trend†
Red and processed meat 100 5506 1.25 (1.09–1.42) 0.001
Poultry meat 20 5506 0.99 (0.94–1.05) 0.84
White fish 15 5506 1.02 (0.98–1.06) 0.39
Fatty fish 15 5506 0.96 (0.91–1.00) 0.072
Milk 200 5506 1.03 (0.99–1.07) 0.11
Yogurt 100 5506 0.97 (0.92–1.03) 0.28
Cheese 30 5506 0.93 (0.86–1.00) 0.055
Eggs 20 5506 0.96 (0.90–1.03) 0.28
EPIC indicates European Prospective Investigation Into Cancer and Nutrition; HR, hazard ratio; IHD, ischemic heart disease; 
and MI, myocardial infarction. 
*HRs are adjusted for age (continuous), smoking status and number of cigarettes per day, history of diabetes mellitus, previous 
hypertension, prior hyperlipidemia, Cambridge physical activity index, employment status, level of education completed, body 
mass index (all categorical, with unknown categories added), current alcohol consumption (nondrinkers and sex-specific fifths of 
intake among drinkers), and calibrated intakes of energy, fruit and vegetables combined, sugars (as percent energy), fiber from 
cereals, and each other food (each continuous), and stratified by sex and EPIC center.
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for the differences in the results of the current study, 
which were based on >7000 IHD events.
We observed no clear association of IHD risk with con-
sumption of either white fish or fatty fish (although there 
were a borderline significant inverse association for fatty 
fish and a significant inverse association for fatty fish in 
the substitution analyses; see below). The possible pro-
tective role of fish in IHD has been investigated for >30 
years. A previous analysis of fish consumption and mor-
tality in EPIC found no evidence that higher intakes of 
total, white, or fatty fish were associated with mortality 
from IHD.18 In contrast, a meta-analysis of 4472 deaths 
in 17 cohort studies suggested that there was an overall 
significant inverse association between fish intake and 
IHD mortality, but the association was not linear, and the 
relative risk in the highest category of fish intake was not 
significantly lower than that in the lowest intake.9
Dairy products are a major source of dietary satu-
rated fatty acids, but prospective observational stud-
ies have generally not shown a higher risk of IHD with 
a higher intake of foods such as milk, yogurt, and 
cheese.19,20 We observed no association of milk with 
risk of IHD, which is consistent with a meta-analysis of 
4391 incident IHD cases in 6 prospective studies.21 We 
observed that yogurt consumption was inversely associ-
ated with risk of IHD. However, this association did not 
persist after exclusion of the initial 4 years of follow-up, 
and it showed heterogeneity by smoking status, with 
no association in never smokers (suggesting therefore 
that the observed association may partly be explained 
by changes in diet resulting from preclinical disease or 
residual confounding by smoking). Yogurt consumption 
is associated with healthy dietary patterns, behaviors, 
and lifestyle factors,22 yet a meta-analysis of 5 prospec-
tive studies (number of cases unclear) reported no as-
sociation between yogurt consumption and risk of 
IHD.23 We also observed that cheese consumption was 
inversely associated with risk of IHD; again, this inverse 
association was not significant after we excluded the 
first 5 years of follow-up, although the estimate was 
only slightly attenuated. A meta-analysis of 8 prospec-
tive studies with 7425 incident cases showed a lower 
risk for IHD in participants with a relatively high intake 
of cheese.24 It has been suggested that cheese has con-
stituents that might act to reduce the risk of IHD, for ex-
ample, that the calcium in cheese forms insoluble soaps 
with fatty acids, thus reducing absorption of saturated 
fatty acids, and that the calcium also binds to bile acids, 
reducing their enterohepatic circulation and possibly 
leading to a cholesterol-lowering effect.19,25
Egg consumption was inversely associated with IHD 
risk overall, but this association was no longer evident 
after exclusion of the first 4 years of follow-up, perhaps 
because of limited power or because people with pre-
clinical disease may have reduced their egg consump-
tion. A recent meta-analysis of 6 prospective studies in-
cluding 5847 incident cases reported no association of 
egg consumption with risk of coronary heart disease,8 
whereas a recent large prospective study in China in-
cluding 31 169 incident cases of IHD reported that egg 
intake was inversely associated with risk26; it is possible 
that the risk associations found in the observational 
studies resulted from the dietary pattern often accom-
panying high egg intake or the cluster of other risk fac-
tors in people with high egg consumption.27
The positive association we observed between red 
and processed meat and risk of IHD might be related to 
the saturated fat content of these foods. However, al-
though dairy products are also relatively rich in saturated 
fats, intake of dairy products was not positively related 
to IHD risk in this study; in fact there was a suggestion 
of an inverse association between cheese intake and fu-
ture risk of IHD. This finding might suggest that different 
food sources of saturated fat and different proportions 
of individual saturated fatty acids contained within meat 
and dairy foods may differ in their impact on risk of IHD, 
which would affect the interpretation of previous stud-
ies of total dietary saturated fatty acids and risk.28 It is 
also possible that plant sources of protein may be asso-
ciated with a lower risk of IHD than animal foods,29 and 
this should be considered in future analyses.
Substitution of Other Animal Foods for 
Red and Processed Meat
Our analyses showed that red meat and processed meat 
were positively associated with risk for IHD, whereas the 
Table 4. HRs* (95% CIs) for First Nonfatal MI or Fatal IHD for 
Substitution of 100-kcal/d Increment in Calibrated Energy Intake From 
Each Food for 100-kcal/d Increment in Calibrated Energy Intake From 
Red and Processed Meat
Food
HR (95% CI), Substituting 100 kcal/d of This Food 
for 100 kcal/d Red and Processed Meat
Poultry meat 0.89 (0.76–1.04)
White fish 1.00 (0.78–1.26)





HR indicates hazard ratio; IHD, ischemic heart disease; and MI, myocardial 
infarction. 
*HRs are adjusted for age (continuous), smoking status and number of 
cigarettes per day, history of diabetes mellitus, previous hypertension, prior 
hyperlipidemia, Cambridge physical activity index, employment status, level 
of education completed, body mass index (all categorical, with unknown 
categories added), current alcohol consumption (nondrinkers and sex-specific 
fifths of intake among drinkers), and calibrated intakes of energy, fruit and 
vegetables combined, sugars (as percent energy), and fiber from cereals (each 
continuous), and each other food as appropriate (each continuous), and 
stratified by sex and EPIC (European Prospective Investigation Into Cancer and 
Nutrition) center. Results are based on 7198 cases among 409 885 participants 
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other animal foods were not associated or were inversely 
associated with risk. We therefore conducted analyses 
modeling isocaloric dietary substitutions, which showed 
that fatty fish, yogurt, cheese, and eggs were associated 
with significantly lower risks for IHD when substituted for 
red and processed meat (15%–24% lower risk per 100 
kcal substituted per day). Plant foods might also be as-
sociated with a lower risk of cardiovascular disease than 
animal foods27 and may be considered in future analyses.
Possible Roles of Plasma Lipids and Blood 
Pressure
The positive associations of red and processed meat 
and the inverse association of cheese consumption with 
the risk of IHD might be explained by the associations 
of these foods with well-established risk factors for IHD 
such as cholesterol fractions and systolic blood pressure. 
Compared with participants in the lowest fifth of intake 
of red and processed meat, those in the top fifth had a 
higher non-HDL cholesterol by 0.19 mmol/L and a higher 
systolic blood pressure by 3.3 mm Hg; the difference in 
systolic blood pressure was larger for processed meat 
than for red meat (3.7 and 2.2 mm Hg, respectively), con-
sistent with previous observations and possibly caused by 
the high salt content of most processed meats.30
On the basis of results from the Emerging Risk Fac-
tors Collaboration and the Prospective Studies Collabo-
ration,31,32 these differences would be expected to be 
associated with higher IHD risks of 8% and 12%, re-
spectively. Such modeling suggests that the observed 
(uncalibrated) 13% higher risk in the top fifth of intake 
of red and processed meat could be readily explained 
by the differences in blood lipids and blood pressure. 
Other mechanisms might also be involved; for exam-
ple, higher intakes of red and processed meat might 
increase the risk of IHD through the conversion of car-
nitine in meat into trimethylamine oxide.33 Compared 
with participants in the lowest fifth of intake of cheese, 
those in the top fifth had lower non-HDL cholesterol 
by 0.10 mmol/L but no significant difference in systolic 
blood pressure. Again on the basis of results from the 
Prospective Studies Collaboration, this difference in 
lipids would be expected to be associated with a 4% 
lower IHD risk, indicating that the observed 12% lower 
IHD risk in the top fifth of intake of cheese might only 
partly be explained by standard lipid fractions.
Strengths and Limitations
Strengths of this study are the large number of cases, 
the prospective design, the wide range of diets across 
Europe, the calibration of the dietary data with 24-hour 
recalls, and the ability to adjust for major risk factors for 
IHD and to estimate the impacts of associations with 
circulating lipids and blood pressure.
As with all observational studies, a potential limitation 
is that the associations may be influenced by confound-
ing by other risk factors. We have adjusted our results for 
major risk factors for IHD, including smoking and BMI, 
as well as socioeconomic factors. However, because the 
magnitudes of the associations we observed were rela-
tively modest, we cannot discount that the results have 
been influenced by residual confounding by adiposity, 
socioeconomic factors, or other unmeasured factors. An-
other potential limitation is that, because of the multi-
center design of the cohort, there were some variations 
in the ascertainment and validation of the end point; the 
positive association of red and processed meat with risk 
for IHD was strong in the countries with complete valida-
tion of cases. It is also possible that associations of specific 
foods with risk may vary between populations as a result 
of differences in associations with other aspects of diet.
CONCLUSIONS
This large prospective study in Europe shows a moder-
ate positive association between consumption of red 
and processed meat and risk of IHD, and it suggests 
a modest inverse association between consumption of 
cheese and IHD risk. It is not clear whether these asso-
ciations reflect causality, but they were consistent with 
the associations of these foods with plasma non-HDL 
cholesterol and for red and processed meat with sys-
tolic blood pressure, which could mediate such effects.
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